Reverse genetics had already been used successfully to create H5N1 candidate vaccines in several laboratories, the CDC’s Daigle wrote. “Any viable viruses that emerge from these processes will be seeded into animals that are considered good models for testing how flu viruses behave in humans… The aim will be to observe whether the animals get sick and whether infected animals can infect others,” he revealed in his e-mail.
